Apellis Historical Financial Ratios
| APLS Stock | USD 33.93 0.21 0.62% |
Apellis Pharmaceuticals is presently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 19.3 or Days Sales Outstanding of 200 will help investors to properly organize and evaluate Apellis Pharmaceuticals financial condition quickly.
Apellis |
About Apellis Financial Ratios Analysis
Apellis PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Apellis Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Apellis financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Apellis Pharmaceuticals history.
Apellis Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Apellis Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Apellis Pharmaceuticals sales, a figure that is much harder to manipulate than other Apellis Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to Apellis Pharmaceuticals. There are two different methods for calculating Apellis Pharmaceuticals invested capital: operating approach and financing approach. Understanding Apellis Pharmaceuticals invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Most ratios from Apellis Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Apellis Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apellis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.At this time, Apellis Pharmaceuticals' Days Payables Outstanding is comparatively stable compared to the past year. Net Debt To EBITDA is likely to gain to 0.51 in 2024, whereas Free Cash Flow Yield is likely to drop (0.09) in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 55.4 | 37.39 | 190.0 | 199.5 | PTB Ratio | 20.09 | 32.3 | 36.52 | 19.3 |
Apellis Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Apellis Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Apellis Stock Analysis
When running Apellis Pharmaceuticals' price analysis, check to measure Apellis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apellis Pharmaceuticals is operating at the current time. Most of Apellis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Apellis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apellis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Apellis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.